MicroTech Medical (Hangzhou) Co., Ltd. — Proxy Solicitation & Information Statement 2026

May 20, 2026

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this notice, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this notice.

微泰医疗

MICROTECH MEDICAL

MicroTech Medical (Hangzhou) Co., Ltd.

微泰醫療器械（杭州）股份有限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 2235)

NOTICE OF THE ANNUAL GENERAL MEETING OF 2025

NOTICE IS HEREBY GIVEN that the annual general meeting (the "AGM") of MicroTech Medical (Hangzhou) Co., Ltd. (the "Company") will be held at Business Conference Room, 3rd Floor, MicroTech Medical Administration Building, No. 108 Liuze Street, Cangqian Street, Yuhang District, Hangzhou, Zhejiang Province, China on Wednesday, June 10, 2026 at 2:30 p.m. for the purposes of considering and, if deemed appropriate, approving the following resolutions.

ORDINARY RESOLUTIONS

1. To consider and approve the 2025 annual report and audited financial statements for 2025;
2. To consider and approve the work report of the Board of Directors for 2025;
3. To consider and approve the work report of the Supervisory Committee for 2025;
4. To consider and approve the final account report for 2025;
5. To consider and approve the proposed 2025 Profit Distribution Plan;
6. To consider and approve the proposed re-appointment of the auditor for 2026 and the authorization to the Board of Directors to fix the remuneration of the auditor; and

SPECIAL RESOLUTIONS

1. To consider and approve the general mandate to allot, issue and deal with additional shares (including the sale or transfer of treasury Shares out of treasury) of the Company, not exceeding 20% of the total number of issued Shares (excluding treasury Shares) as at the date of passing this resolution; and

---

1. To consider and approve the general mandate to repurchase H Shares of the Company, not exceeding 10% of the total number of issued H Shares (excluding treasury Shares) as at the date of passing this resolution.

AS REPORTING DOCUMENT

1. To review the work report of the independent non-executive Directors for 2025.

Details of the above resolutions proposed at the AGM are contained in the Circular, which is available on the websites of the Stock Exchange (www.hkexnews.hk) and the Company (www.microtechmd.com).

By Order of the Board
MicroTech Medical (Hangzhou) Co., Ltd.
Zheng Pan
Chairman of the Board

Hangzhou, the PRC, May 20, 2026

Notes:

(i) Unless the context otherwise stated, capitalized terms used in this notice shall have the meanings as those defined in the circular of the Company dated May 20, 2026.

(ii) Any shareholder of the Company entitled to attend and vote at the AGM is entitled to appoint one or more proxies to attend and, on a poll, vote instead of him/her. A proxy need not be a member of the Company.

(iii) The instrument appointing a proxy shall be in writing under the hand of the appointer or of his/her attorney duly authorized in writing or, if the appointer is a corporation, either under its seal or under the hand of any officer or attorney duly authorized.

(iv) In order to be valid, the form of proxy together with the power of attorney or other authority, if any, under which it is signed or a notarially certified copy of such power or authority, must be deposited with Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong (for holders of H shares) or the Company's office at No. 108 Liuze Street, Cangqian Street, Yuhang District, Hangzhou, Zhejiang Province, China (for holders of unlisted shares) as soon as practicable but in any event not less than 24 hours before the time appointed for holding the AGM (i.e. not later than June 9, 2026 at 2:30 p.m.), or any adjourned meeting thereof (as the case may be).

(v) Completion and return of the form of proxy shall not preclude the shareholders of the Company (the "Shareholders") from attending and voting in person at the AGM or at any adjourned meeting thereof (as the case may be) should they so wish, and in such event, the form of proxy shall be deemed to be revoked.

---

(vi) Where there are joint registered holders of any share, any one of such joint holders may vote, either in person or by proxy, in respect of such share as if he/she was solely entitled thereto, but if more than one of such joint holders are present at the AGM, whether in person or by proxy, the joint registered holder present whose name stands first on the register of members of the Company in respect of the shares shall alone be entitled to vote in respect thereof.

(vii) For the purpose of determining the H shareholders of the Company entitled to attend and vote at the AGM, the register of members of H shares of the Company will be closed from Thursday, June 4, 2026 to Wednesday, June 10, 2026 (both days inclusive). The record date for determining the entitlement of the Shareholders to attend and vote at the AGM will be June 10, 2026.

(viii) Shareholders shall produce their identity documents and supporting documents in respect of the shares of the Company held when attending the AGM. If corporate Shareholders appoint authorised representative to attend the AGM, the authorized representative shall produce his/her identity documents and a notarially certified copy of the relevant authorization instrument signed by the board of directors or other authorised parties of the corporate Shareholders or other notarially certified documents allowed by the Company. Proxies shall produce their identity documents and the proxy form signed by the Shareholders or their attorney when attending the AGM.

(ix) Shareholders attending the AGM shall be responsible for their own travel and accommodation expenses.

(x) All resolutions at the AGM will be taken by poll (except where the chairman decides to allow a resolution relating to a procedural or administrative matter to be voted on by a show of hands) pursuant to the Listing Rules. The results of the poll will be published on the websites of the Stock Exchange and the Company in accordance with the Listing Rules.

(xi) All times refer to Hong Kong local time, except as otherwise stated.

(xii) For any matter relating to the AGM, please contact the securities representative or the investor relationship department of the Group (via email: zhengdai@microtechmd.com; ir@microtechmd.com, respectively, or telephone: 0571-88566373-866).

As at the date of this notice, the executive Directors of the Company are Dr. Zheng Pan, Dr. Yu Fei, Dr. Shi Yonghui and Ms. Liu Xiu; the non-executive Directors are Mr. Mao Shuo and Ms. Gao Yun; and the independent non-executive Directors are Dr. Li Lihua, Ms. Wang Chunfeng, Mr. Ho Kin Cheong Kelvin and Dr. Cheng Hua.

• 3 -